HIV 1 News and Research

RSS

State roundup: No Mass. insurance mandate referendum

If you chafe against the Massachusetts requirement that you have health insurance, sorry but you won't have a chance to vote against it -; not in the next election, anyway. Backers of a ballot measure to repeal the state's insurance mandate sent out an email last week saying they had failed to gather the needed signatures.

30 Nov 2011

AIDS 2012 conference to be held in Washington

Registration, abstract and programme activity submissions for the XIX International AIDS Conference (AIDS 2012), to be held from 22 to 27 July 2012 in Washington, D.C., open December 1 online at www.aids2012.org.

30 Nov 2011

Experts available to discuss on HIV/AIDS prevention at Penn Nursing

Experts in HIV/AIDS prevention at the University of Pennsylvania School of Nursing are available to talk with media for stories on World AIDS Day, which is on December 1.

30 Nov 2011

Cases of two AIDS patients renew hope of AIDS cure for many scientists, New York Times reports

The New York Times profiles two AIDS patients whose cases "suggest to many scientists that curing AIDS may be achievable," according to the newspaper. "One man, the so-called Berlin patient, apparently has cleared his HIV infection, albeit by arduous bone marrow transplants," and the other, "a 50-year-old man in Trenton, N.J., underwent a far less difficult gene therapy procedure. While he was not cured, his body was able to briefly control the virus after he stopped taking the usual antiviral drugs, something that is highly unusual," the newspaper writes.

29 Nov 2011

New trends in HIV/AIDS prevalence

According to a latest report released this Monday, Toronto has more HIV and AIDS cases than ever before, with an estimated one in 120 adults in the city now HIV-positive. In all of Ontario, the number of people living with HIV-AIDS grew by 31 per cent between 2003 and 2008 and that number continues to expand.

29 Nov 2011

Testing of vaginal gel for HIV prevention halted after interim results showed no difference from placebo

Researchers involved with a multi-armed clinical trial designed to evaluate different antiretroviral (ARV) interventions for HIV prevention on Friday announced the arm testing a vaginal gel had been stopped because it was not working, the New York Times reports.

29 Nov 2011

VOICE continues testing daily use of ARV Truvada among women in sub-Saharan Africa

VOICE, an HIV prevention trial that has been evaluating two antiretroviral (ARV)-based approaches for preventing the sexual transmission of HIV in women - daily use of one of two different ARV tablets or of a vaginal gel - has stopped testing the gel.

29 Nov 2011

NIH awards $3.2M for development of highly efficient system of generating nucleic acid molecules

The National Institutes of Health (NIH) has awarded $3.2 million to a team of preeminent engineering, chemistry, and biology researchers to develop a highly efficient system of generating nucleic acid molecules, called aptamers.

29 Nov 2011

Tenofovir gel no more effective than placebo gel in preventing HIV

An independent review of the VOICE study, funded by the National Institute of Allergy and Infectious Diseases (NIAID) and conducted by the Microbicide Trials Network, determined that tenofovir gel was no more effective than placebo gel in preventing HIV.

28 Nov 2011

Mass immunization with cervical cancer vaccine switched to a more effective variety

Cervarix is currently offered to girls aged 12 and 13 years to protect against strains of the sexually transmitted human papillomavirus (HPV), which causes most cases of cancer of the cervix, the neck of the womb. Cervarix was picked by the Labour government for the first four-year phase of the NHS programme in 2008 because it offered ‘best overall value’ and more than five million doses have been given.

27 Nov 2011

Funds for AIDS, tuberculosis and malaria dry up

A global fund organization against three killer diseases says it has run out of money to pay for new grant programs for the next two years. An official with the Global Fund to Fight AIDS, Tuberculosis and Malaria said Thursday that it has been forced to cease giving new grants until 2014 because of global economic woes brought on by debt crises in the U.S. and Europe.

27 Nov 2011

Sub-Saharan African countries lose billions of dollars due to migration of doctors

Sub-Saharan African countries that train and invest in their doctors end up losing billions of dollars as the clinicians leave to work in developed nations, finds research published on bmj.com today.

24 Nov 2011

IPS reports on child poverty in Lesotho

"The triple threat of HIV, poverty and food insecurity is increasingly exposing children to abuse, exploitation and other human rights violations" in Lesotho, Inter Press Service reports in an article examining child poverty in the small southern African country.

24 Nov 2011

NIH-led study advances HIV vaccine research

HIV is coated in sugars that usually hide the virus from the immune system. Newly published research reveals how one broadly neutralizing HIV antibody actually uses part of the sugary cloak to help bind to the virus. The antibody binding site, called the V1/V2 region, represents a suitable HIV vaccine target, according to the scientists who conducted the study. In addition, their research reveals the detailed structure of the V1/V2 region, the last part of the virus surface to be visualized at the atomic level.

24 Nov 2011

Interview with AIDS economist Mead Over

ONE member Erin Hohlfelder presents excerpts of an interview she conducted with AIDS economist Mead Over in this ONE blog post. Over discusses his new book, titled "Achieving an AIDS Transition: Preventing Infections to Sustain Treatment," AIDS program financing, government roles, and creating incentives for HIV prevention program success.

24 Nov 2011

Community-based program battles gender-based violence

Hillary Anderson, a communications intern for Management Sciences for Health (MSH), writes in this post on MSH's "Global Health Impact" blog about the organization's Community-based Family Planning and HIV & AIDS Services (CFPHS) project, which "worked to address gender-based violence (GBV) in Malawi through behavior change communication (BCC) activities."

24 Nov 2011

Bloomberg examines Trans-Pacific Partnership trade initiative and potential impact to U.S. global efforts to tackle HIV

Bloomberg examines how a trade agreement being negotiated by leaders of the nine Trans-Pacific Partnership (TPP) countries -- Australia, Brunei Darussalam, Chile, Malaysia, New Zealand, Peru, Singapore, Vietnam, and the United States -- could potentially make it more difficult for people in TPP nations to get new generic drugs and may impact U.S.-led global efforts to tackle HIV/AIDS as outlined by Secretary of State Hillary Clinton in a recent speech at the NIH.

24 Nov 2011

George W. Bush to travel to Africa to raise awareness about cervical, breast cancer

Former President George W. Bush will travel next month with former first lady Laura Bush and officials with the George W. Bush Institute to Tanzania, Zambia and Ethiopia "where they'll visit clinics and meet with governmental and health care leaders ... to raise awareness about cervical and breast cancer, an effort he calls a 'natural extension' of" the PEPFAR program launched during his presidency, the Associated Press reports.

23 Nov 2011

Partnerships, additional funding allow for expansion of PEPFAR to combat cervical cancer

In this post in the Public Health Institute's "Dialogue4Health" blog, Jeffrey Meer, director of PHI's Washington-based advocacy on global health, writes that "a significant expansion of PEPFAR's existing work to combat cervical cancer" through a partnership with the George W. Bush Institute known as Pink Ribbon Red Ribbon (PRRR); a 50 percent increase in the U.S. government's "commitment to screen and treat for this type of cancer from $20 million over five years to $30 million"; and additional funding from Susan G. Komen for the Cure "to expand breast cancer awareness and prevention among the same target population of women receiving care at PEPFAR-funded HIV service sites" has allowed "the wonderfully robust PEPFAR prevention and treatment platform, considered one of the great global health achievements in recent times, to be made available to a whole new type of prevention -- in this case for a non-communicable disease (NCD)."

23 Nov 2011

University of Liverpool introduces HEP i-chart for HCV patients

The University of Liverpool has launched an iphone app, HEP i-chart, that provides Hepatitis C (HCV) patients with quick and easy access to the latest information about drug interactions.

23 Nov 2011

HIV 1 News and Research

State roundup: No Mass. insurance mandate referendum

AIDS 2012 conference to be held in Washington

Experts available to discuss on HIV/AIDS prevention at Penn Nursing

Cases of two AIDS patients renew hope of AIDS cure for many scientists, New York Times reports

New trends in HIV/AIDS prevalence

Testing of vaginal gel for HIV prevention halted after interim results showed no difference from placebo

VOICE continues testing daily use of ARV Truvada among women in sub-Saharan Africa

NIH awards $3.2M for development of highly efficient system of generating nucleic acid molecules

Tenofovir gel no more effective than placebo gel in preventing HIV

Mass immunization with cervical cancer vaccine switched to a more effective variety

Funds for AIDS, tuberculosis and malaria dry up

Sub-Saharan African countries lose billions of dollars due to migration of doctors

IPS reports on child poverty in Lesotho

NIH-led study advances HIV vaccine research

Interview with AIDS economist Mead Over

Community-based program battles gender-based violence

Bloomberg examines Trans-Pacific Partnership trade initiative and potential impact to U.S. global efforts to tackle HIV

George W. Bush to travel to Africa to raise awareness about cervical, breast cancer

Partnerships, additional funding allow for expansion of PEPFAR to combat cervical cancer

University of Liverpool introduces HEP i-chart for HCV patients

Decoding Cannabis: Differentiating Hemp and Marijuana

Deciphering the Microbiome with The Microsetta Initiative

Leveraging the power of automation to boost research

Latest News